The Opportunity of TEMPO and ACCESS for Digital Health Device Manufacturers

Start
The Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) are offering digital health device manufacturers a combination of a new pathway to market and a payment system. Our FDA: Drug & Device Team explores how the combination offers an attractive opportunity for new use cases in a real-world setting….
By: Alston & Bird
Previous Story

FDIC extends comment period on proposed requirements for banks seeking to issue stablecoins under GENIUS Act

Next Story

Surveillance Pricing: A Burgeoning Privacy Issue